Tübingen University Hospital in Germany has showcased its new revolutionary Elekta Unity cancer treatment system.
The Elekta Unity MR-linac is located in the hospital’s radiation oncology department and combines advanced diagnostic MR imaging and precision radiotherapy technologies, enabling doctors to focus on tumours, avoid disrupting healthy tissues and create personalised therapies for patients.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Elekta’s president and CEO Richard Hausmann said: “Elekta Unity ushers in a new level of personalised patient care in radiation therapy.
“We are pleased to celebrate with Tübingen University Hospital as they prepare to bring our shared vision of transformative cancer therapy to their patients. Elekta is committed to improving, prolonging and saving lives and to supporting our customers as they work with patients every day to achieve these critical goals.”
Tübingen University Hospital professor Dr Daniel Zips added: “Elekta Unity will give our clinicians the ability to see crystal-clear, high-field MR images while the radiation is being delivered. Tumours and surrounding tissues can be located and their movement monitored with accuracy at the time of treatment. This allows treatment plans to be adapted while the patient is on the table in response to changes in tumour position, shape, biology and the relationship to sensitive organs over time.
“We expect that this enhanced real-time visualisation of cancer targets will allow us to avoid healthy tissue as much as possible during the delivery of therapeutic radiation, leading to improved outcomes for cancer patients and positioning Unity as a truly unique way to treat cancer.”
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe hospital has imaged the first patients with its new system and has calculated the first MR-based treatment plans on when the Unity CE mark was issued. The hospital expects to use Elekta Unity to treat a wide range of cancers and potentially enable new therapeutic options for hard-to-treat cancers. Anatomical structures that were previously deemed unsuitable for radiotherapy could now be considered for treatment at the facility.
Elekta Unity has a CE mark but is not yet available for commercial distribution or sale in the US.
